ÂÜÀòÂÒÂ×

Melissa Devsam is a seasoned professional in the pharmaceutical and healthcare industries, currently serving as the Strategic Pricing Lead at MSD Australia & New Zealand since April 2018. With extensive experience in leadership roles, Melissa has been integral to the General Medicine Leadership Team and has acted as the Commercial Lead for Lagevrio, a COVID-19 antiviral treatment. Melissa's previous positions include Associate Director and Senior Brand Manager, focusing on antibiotic portfolios and diabetes products. Prior roles at Abbott, Actelion, CSL Behring, Alphapharm, and CSIRO have equipped Melissa with a broad skill set in marketing, brand management, and product launch strategies across various medical specialties. Melissa holds an MBA from AGSM @ UNSW Business School and a Bachelor of Biotechnology (Hons) from Flinders University.